Ole Vahlgren (born 1963) is Board member since 2020. He is also Member of the Audit Committee.
He has also more than 25 years experience from business development and strategy work in international and global pharmaceutical companies such as H. Lundbeck and Otsuka.
Ole holds a MSc from Technical University of Denmark, Copenhagen. MBA from Business School of Copenhagen.
Other current appointments: Chief Executive Officer, AJ Vaccines A/S, board member of Go-PEN Aps and Blue Cell Therapeutics.
Holdings: 10,000 shares.
Independent in relation to the company and its management and the company’s major shareholders.